Administrative Core

行政核心

• 批准号: 9186925
• 负责人: TOM A ELASY
• 金额: $ 12.09万
• 依托单位: VANDERBILT UNIVERSITY MEDICAL CENTER
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至 2021-07-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9186925
• 关键词: Advisory Committees; Appointment; Area; Attention; Behavior Therapy; Clinic; Collaborations; Communities; Diabetes Mellitus; Doctor of Medicine; Doctor of Philosophy; Effectiveness; Ensure; Faculty; Funding; Goals; Information Technology; Institute of Medicine (U.S.); Internal Medicine; Journals; Leadership; Michigan; North Carolina; Positioning Attribute; Public Health; Research; Research Personnel; Research Training; Resources; Schedule; Schools; Services; Technology; Translational Research; Universities; Update; Visit; Walkers; Work; college; experience; implementation science; medical schools; meetings; member; organizational structure; programs; skills; technology validation; web site

The Vanderbilt CDTR is a distinct organizational, interdisciplinary program involving 38 actively funded faculty distributed among three schools and four colleges of the University. Five additional funded faculty members whose primary appointment is at Meharry Medical School also participate. Under the leadership of Dr. Elasy, the core will be responsible for the allocation and oversight of Center resources and the coordination and integration of the CDTR components and activities. In particular, the administrative core actively coordinates and oversees Pilot and Feasibility activities as well as Enrichment activities. A web site has been created (https://labnodes.vanderbilt.edu/cdtr) and is carefully maintained. There is general continuity in the leadership of the Center with a change in the leadership of a regional core for Behavioral Intervention Technologies and Services (Osborn) and a new leader for the enrichment core (Wilkins). The Vanderbilt CDTR continues under the direction of Tom A. Elasy, M.D., who is PI/Director of the Center. Dr. Elasy is the Ann and Roscoe R. Robinson Chair in the Diabetes Center, Director of the Vanderbilt Division of General Internal Medicine and Public Health, former director of the Vanderbilt Eskind Diabetes Clinic, and has directed the current CDTR for the past 5 years. He is assisted by an Associate Director (Russell Rothman, M.D.) and a Scientific Executive Committee (David Schulndt, Ph.D., Shari Barkin, M.D., Chandra Osborn, Ph.D., Robert Greevey, Ph.D., Consuelo Wilkins, M.D., Margaret Hargraeves, Ph.D.). An internal advisory group consists of Al Powers, M.D. (Director, Vanderbilt Diabetes Research and Training Center), Gordon Bernard, M.D. (Director, Vanderbilt CTSA) and Robert Dittus, M.D., (Director, Vanderbilt Institute for Medicine and Public Health). All three internal advisory members hold senior positions within Vanderbilt enhancing the visibility and effectiveness of the center. This group of investigators brings considerable scientific experience, administrative and managerial skills, and continuity to the Vanderbilt CDTR. An external advisory committee has visited Vanderbilt in conjunction with enrichment activities (Elizabeth Walker, Ph.D. from Einstein, William Herman, M.D. from the University of Michigan, and Thomas Keyserling, M.D. from the University of North Carolina ) and bring national expertise in the areas of disparity research, community engaged research, information technology and implementation science. Dr. Elasy will provide an annual update to the external and internal advisory committee to reflect progress on center goals. The Director, Associate Director and Scientific Executive Committee will meet monthly to review core utilization, discuss enrichment activities, review progress of junior faculty (funded and not yet funded) and consider additional opportunities for collaboration beyond scheduled seminars, journal clubs, and local works-in- progress.

Vanderbilt CDTR是一个独特的组织跨学科计划，涉及38个积极资助的教师 分布在大学的三所学校和四所学院中。另外五个资助的教师 他的主要任命是在Meharry医学院参加的。在Elasy博士的领导下， 核心将负责中心资源和协调的分配和监督以及 CDTR组件和活动的集成。特别是，行政核心主动协调 并监督飞行员和可行性活动以及丰富活动。已经创建了一个网站 （https://labnodes.vanderbilt.edu/cdtr）并经过精心维护。 该中心领导的一般连续性随着区域核心领导的变化而改变 行为干预技术和服务（OSBORN）和富集核心的新领导者 （威尔金斯）。 Vanderbilt CDTR在M.D.的汤姆·A·埃尔斯（Tom A. Elasy）的指导下继续 中心。 Elasy博士是Ann and Roscoe R. Robinson博士糖尿病中心主席，范德比尔特主任 通用内科和公共卫生部，前范德比尔特埃斯KIND糖尿病的主任 诊所，并在过去的5年中指示当前的CDTR。他得到副主任的协助 （Russell Rothman，M.D。）和科学执行委员会（David Schulndt，Ph.D。，Shari Barkin，M.D。 钱德拉·奥斯本（Chandra Osborn）博士，罗伯特·格里维（Robert Greevey），博士，Consuelo Wilkins，M.D。，Margaret Hargraeves，Ph.D。）。一个 内部咨询小组由Al Powers，医学博士组成（范德比尔特糖尿病研究和培训主任 中心），戈登·伯纳德（Gordon Bernard） 医学与公共卫生研究所）。所有三个内部咨询成员都担任高级职位 范德比尔特（Vanderbilt）增强了中心的可见性和有效性。这组调查人员带来了 范德比尔特CDTR的大量科学经验，行政和管理技能以及连续性。 外部咨询委员会与丰富活动一起访问了范德比尔特（伊丽莎白 沃克博士来自爱因斯坦，密歇根大学的威廉·赫尔曼（William Herman） 北卡罗来纳大学的医学博士），并在差异研究领域带来了国家专业知识， 社区参与研究，信息技术和实施科学。 Elasy博士将提供 向外部和内部咨询委员会的年度更新，以反映中心目标的进展。这 董事，副主任兼科学执行委员会将每月开会以审查核心利用率， 讨论丰富活动，审查初级教师的进度（资助且尚未资助），并考虑 除计划研讨会，期刊俱乐部和当地工作的其他机会 进步。